Rocket Pharmaceuticals, Inc.

RCKT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001281895

SEC filings (opens in a new tab)

In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.

Q4 2021 vs. Q3 2021

How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of RCKT: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Of which not filed for Q4 2021	Q4 2021	Change
Holders	147	2	148	+3
Shares	62.0M	233	63.2M	+1.25M (+2.0%)
Value	$1.85B	$6.00K	$1.38B	−$469.8M (−25.4%)

2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to RCKT in Q4 2021
Institution	Shares	Value	% of portfolio
M28 Capital Management LP	495,280	$10.8M	8.44%
Natixis	225,394	$4.92M	0.02%
Millennium Management LLC	221,013	$4.83M	0.01%
Prosight Management, LP	128,705	$2.81M	1.87%
Marshall Wace, LLP	95,569	$2.08M	0.00%
Harbor Capital Advisors, Inc.	88,385	$1.93M	0.70%
Voloridge Investment Management, LLC	54,371	$1.19M	0.01%
Squarepoint Ops LLC	41,771	$912.0K	0.00%
Toronto Dominion Bank	40,588	$886.0K	0.00%
Vontobel Holding Ltd.	38,518	$883.0K	0.01%
HRT Financial LP	36,251	$791.0K	0.00%
Ergoteles LLC	35,843	$782.0K	0.03%
Gsa Capital Partners LLP	35,704	$779.0K	0.10%
Alpha Paradigm Partners, LLC	35,302	$771.0K	0.31%
Qube Research & Technologies Ltd	28,316	$618.0K	0.00%
Jump Financial, LLC	26,600	$581.0K	0.04%
Corton Capital Inc.	10,873	$237.0K	0.11%
New York Life Investments Alternatives	9,666	$211.0K	0.14%
Ensign Peak Advisors, Inc	7,730	$169.0K	0.00%
Allspring Global Investments Holdings, LLC	928	$20.0K	0.00%
Aquatic Capital Management LLC	200	$4.00K	0.01%
Washington Trust Advisors, Inc.	72	$2.00K	0.00%
CWM, LLC	36	$1.00K	0.00%
Tarbox Family Office, Inc.	49	$1.00K	0.00%
Covestor Ltd	17	$0	0.00%

Sold out (22)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of RCKT in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Rock Springs Capital Management LP	403,270	$12.1M
Principal Financial Group Inc	20,614	$616.0K
Cinctive Capital Management LP	18,000	$538.0K
Dynamic Technology Lab Private Ltd	17,170	$513.0K
Blueshift Asset Management, LLC	14,026	$419.0K
Campbell & CO Investment Adviser LLC	11,100	$332.0K
Cetera Advisor Networks LLC	10,095	$302.0K
Victory Capital Management Inc	9,066	$271.0K
Cobblestone Capital Advisors LLC	9,000	$269.0K
Los Angeles Capital Management LLC	8,190	$245.0K
Amalgamated Bank	7,238	$216.0K
Meeder Asset Management Inc	4,221	$127.0K
Banque Cantonale Vaudoise	3,000	$90.0K
Harbour Investments, Inc.	2,230	$67.0K
Penserra Capital Management LLC	1,455	$43.0K
TCI Wealth Advisors, Inc.	122	$4.00K
Parallel Advisors, LLC	93	$3.00K
Glassman Wealth Services	57	$2.00K
Evolution Wealth Advisors, LLC	60	$2.00K
Meridian Wealth Partners, LLC	39	$1.00K
Bellevue Asset Management, LLC	34	$1.00K
Jefferies Group LLC	1	$30

Not filed for Q4 2021 yet (2)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCKT in Q3 2021 that haven't filed for Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Berman Capital Advisors, LLC	133	$3.00K
Heritage Wealth Management, LLC	100	$3.00K